A phase I study to evaluate the safety, tolerance and pharmacokinetics of anti-Shiga toxin hyperimmune equine F (ab') 2 fragments in healthy volunteers.
Yanina HiriartPaula ScibonaAugusto FerrarisWaldo H BellosoValeria BerutoGarcia-Bournissen FacundoVanesa ZylbermanLuciana MuñozFernando GoldbaumLinus SpatzMariana ColonnaSantiago SanguinetiVentura A SimonovichPublished in: British journal of clinical pharmacology (2024)
The results obtained in this first-in-human study support progression into the phase 2 trial in children with HUS.
Keyphrases